Advances in Clinical and Experimental Medicine

Title abbreviation: Adv Clin Exp Med
JCR Impact Factor (IF) – 2.1
5-Year Impact Factor – 2.2
Scopus CiteScore – 3.4 (CiteScore Tracker 3.4)
Index Copernicus  – 161.11; MEiN – 140 pts

ISSN 1899–5276 (print)
ISSN 2451-2680 (online)
Periodicity – monthly

Download original text (EN)

Advances in Clinical and Experimental Medicine

2020, vol. 29, nr 6, June, p. 751–755

doi: 10.17219/acem/121935

Publication type: review article

Language: English

License: Creative Commons Attribution 3.0 Unported (CC BY 3.0)

Download citation:

  • BIBTEX (JabRef, Mendeley)
  • RIS (Papers, Reference Manager, RefWorks, Zotero)

Organ of hearing and balance in peri- and postmenopausal women. Effects of hormone replacement therapy on hearing and balance in peri- and post-menopausal women: The current state of knowledge

Krystyna Orendorz-Frączkowska1,A,B,C,D,E,F, Hanna Temporale1,A,B,C,D,F

1 Department and Clinic of Otolaryngology Head and Neck Surgery, Wroclaw Medical University, Poland


Sensory-neural hearing loss in people over 50 − senile deafness − is currently an increasing problem due to the growing proportion of the elderly people in the population. We can find a number of worldwide publications on hearing loss and dizziness in peri-menopausal women, but the data is inconsistent. Reports describing the influence of sex hormones on the ear and its aging are similarly controversial. This review attempts to summarize the current state of knowledge regarding hearing and balance in women during menopause, based on recent studies in this field. It describes the possible causes of hearing and balance impairment in post-menopausal women other than the mere physiological aging of the ear. The review concludes that impairment of hearing and balance is significantly related to osteoporosis, which results from estrogen deficiency during menopause. It also presents the results of studies on the impact of hormone replacement therapy (HRT) and of particular hormonal components of HRT on hearing and balance. The European population is aging, so accurate knowledge about the effects of HRT on hearing and balance is crucial in the context of improving the quality of life of elderly women through appropriate qualification for hormone substitution therapy. Further detailed and extensive study is necessary to verify the impact of sex hormones on hearing in post-menopausal women, taking into account the type of HRT used, serum hormone levels and the presence or absence of osteoporosis.

Key words

dizziness, imbalance, benign paroxysmal positional vertigo, menopause, hearing loss

References (32)

  1. Trott S, Cline T, Weihing J, Beshear D, Bush M, Shinn J. Hormones and hearing: Central auditory processing in women. J Am Acad Audiol. 2019;30(6):493–501.
  2. Orendorz-Frączkowska K, Pośpiech L, Gawron W, Jędrzejuk D. Zawroty głowy u kobiet w okresie menopauzy. Otolaryngol Pol. 2004;58(2): 359–364.
  3. Greene J. HRT has an uncertainty problem. Does compounding make it worse? Manag Care. 2019;28(2):32–35.
  4. Hederstierna C, Hultcrantz M, Collins A. Hearing in women at menopause: Prevalence of hearing loss, audiometric configuration and relation to hormone replacement therapy. Acta Otolaryngol. 2017; 127(2):149–155.
  5. Berk E, Koca TT, Guzelsov SS, Nacitarhan V, Demirel A. Evaluation of the relationship between osteoporosis, balance, fall risk and audiological parameters. Clin Rheumatol. 2019;38(11):3261–3268. doi:10. 1007/s10067-019-04655-6
  6. Owada S, Suzuki M. The relationship between vasomotor symptoms and menopause-associated dizziness. Acta Otolaryngol. 2014;134(2): 146–150. doi:10.3109/00016489.2013.841991
  7. Terauchi M, Odai T, Hirose A, et al. Dizziness in peri- and post-menopausal women is associated with anxiety: A cross-sectional study. BioPsychSocial Med. 2018;12(1). doi:10.1186/s13030-018-0140-1
  8. Lobo RA. Hormone-replacement therapy: Current thinking. Nat Rev Endocrinol. 2017;13(4):220–231.
  9. Marjoribanks J, Farquhar C, Roberts H, Lethaby A, Lee J. Long-term hormone therapy for peri-menopausal and post-menopausal women. Cochrane Database Syst Rev. 2017;1(1):CD004143. doi:10.1002/ 1465185. CD004143.pub5
  10. Kahveci OK, Demirdal US, Yucedag F, Cerci U. Patients with osteoporosis have higher incidence of sensory-neural hearing loss. Clin Otolaryngol. 2014;39(3):145–149.
  11. Kshithi K, Vijendra Shenoy S, Panduranga Kamath M, et al. Audiological profiling in post-menopausal women with osteoporosis. Am J Otolaryngol. 2018;39(3):271–276.
  12. Kosus N, Kosus A, Turhan N, Kurtaran H. Hearing levels in menopausal women and the effect of tibolone on audiological functions. J Obstet Gynaecol. 2012;32(3):294–297.
  13. Curhan SG, Eliassen AH, Eavey RD, Wang M, Lin BM, Curhan GC. Menopause and post-menopausal hormone therapy and risk of hearing loss. Menopause. 2017;24(9):1049–1056. doi:10.1097/GME.0000000 000000878
  14. Chen PJ, Chung CH, Chien WC, Chen HC. Hormone therapy is not associated with the risk of sudden sensory-neural hearing loss in post-menopausal women: A 10-year nationwide population-based study. Menopause. 2019;26(8):892–898. doi:10.1097/GME.0000000000 001323
  15. Chen HC, Chung CH, Chen VCF, Wang YC, Chien WC. Hormone replacement therapy decreases the risk of tinnitus in menopausal women: A nationwide study. Oncotarget. 2018;9(28):19807–19816.
  16. Lee SS, Han KD, Joo YH. Association of perceived tinnitus with duration of hormone replacement therapy in Korean post-menopausal women: A cross-sectional study. BMJ Open. 2017;7(7):e013736. doi:10. 1136/bmjopen-2016-0137336
  17. Guimaraes P, Fristina S, Mapes F. Progestin negatively affects hearing in aged women. Proc Natl Acad Sci U S A. 2006;103(38):14246–14249.
  18. Price K, Zhu X, Guimares P. Hormone replacement therapy diminishes hearing in peri-menopausal mice. Hear Res. 2019;252(1–2):29–36.
  19. Williamson TT, Ding B, Zhu X, Frisina RD. Hormone replacement therapy attenuates hearing loss: Mechanisms involving estrogen and the IGF-1 pathway. Aging Cell. 2019;18:e12939. doi:10.1111/acel.12939
  20. Kim JY, Lee SB, Lee CH, Kim HM. Hearing loss in post-menopausal women with low bone mineral density. Auris Nasus Larynx. 2016;43(2): 155–160.
  21. Yoo JI, Park KS, Seo SH, Park HW. Osteoporosis and hearing loss: Findings from the Korea National Health and Nutrition Examination Survey 2009–1011. Braz J Otorhinolaryngol. 2019;S1808-8694(18)30488-9. doi:10.1016/j. bjorl.2018.12
  22. Mendy A, Vieira ER, Albatineh AN, Lowry D, Gasana J. Low bone mineral density is associated with balance and hearing impairment. Ann Epidemiol. 2014;24(1):58–62. doi:10.1016/j. annepidem.2013.10.012
  23. Jung DJ, Cho HH, Lee KY. Association of bone mineral density with hearing impairment in post-menopausal women in Korea. Clin Exp Otorhinolaryngol. 2016;9(4):319–325.
  24. Upala S, Rattanawong P, Vutthikraivit W, Sanguankeo A. Significant association between osteoporosis and hearing loss: A systematic review and meta-analysis. Braz J Otorhinolaryngol. 2017;83(6): 646–652.
  25. Rzewnicki I, Knapp P, Kluz-Kowal AB, Kuryliszyn-Moskal A, Terlikowski R. Activity of vestibular organs in menopausal women non-users hormone replacement therapy (HRT). Otolaryngol Pol. 2010;64(1):10–14.
  26. Zhai XY, Liu B, Zhang YH, et al. Analysis of BPPV in patients with bone mineral density results [in Chinese]. Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2016;30(23):1865–1869.
  27. Zhang YM, Yang ZD, Li WX, Shi C, Yu YF. The relationship between the recurrence of benign paroxysmal positional vertigo and the level of bone mineral as well as estrogen in post-menopausal women [in Chinese]. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2017;7; 52(12):881–884. doi:10.3760/cma.issn. 1673-0860.2017.12.001
  28. Gu CY, Han WW, Wu YQ, Fan ZY, Chen CJ, Chen HM. Study on bone metabolism in post-menopausal women with idiopathic benign paroxysmal positional vertigo [in Chinese]. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2018;53(2):134–137. doi:10. 3760/cma.issn.1673-0860.2018.02.010
  29. Choi HG, Lee JK, Kong IG, Lim H, Kim SY. Osteoporosis increase the risk of benign paroxysmal positional vertigo: A nested case-control study using a national sample cohort. Eur Arch Otorhinolaryngol. 2019;276(2):335–342. doi:10. 1007/s00405-018-5230-y
  30. Liu DH, Kuo CH, Wang CT, et al. Age-related increases in benign paroxysmal positional vertigo are reversed in women taking estrogen replacement therapy: A population-based study in Taiwan. Front Aging Neurosci. 2017;12;9:404. doi:10.3389/fnagi.2017.00404
  31. Owada S, Yamamoto M, Suzuki M, Yoshida T, Nomura T. Clinical evaluation of vertigo in menopausal women [in Japanese]. Nihon Jibiinkoka Gakkai Kaiho. 2012;115(5):534–539.
  32. Yang L, Xu Y, Zhang Y, Vijayakumar S, Jones SM, Lundberg YYVW. Mechanism underlying the effects of estrogen deficiency on otoconia. J Assoc Res Otolaryngol. 2018;19(4):353–362.